Advancing the pharmacist’s role in promoting the appropriate and safe use of dietary supplements

Harnett, Joanna; Ung, Carolina Oi Lam; Hu, Hao; Sultani, Mustafa; Desselle, Shane P.

doi:10.1016/j.ctim.2019.04.018

Cited by 36 publications

(52 citation statements)

References 24 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Despite rising consumption and current safety concerns around some CMs, CMs remain unscheduled. And while CMs are clearly not drugs of abuse, there is an increasing demand from professional organizations, and within the literature, advocating for pharmacists and pharmacy personnel to adopt heightened professional duties as related to the supply of CMs [15]. According to the position statement issued by the Pharmaceutical Society of Australia, "pharmacists are recommended to assume the responsibility of providing sound evidence-based advice to assist consumers in making informed decisions regarding CMs" [16].…”

Section: Introductionmentioning

confidence: 99%

Impact of Up-Scheduling Medicines on Pharmacy Personnel, Using Codeine as an Example, with Possible Adaption to Complementary Medicines: A Scoping Review

et al. 2020

Self Cite

View full text Add to dashboard Cite

Within Australia, vitamins, minerals, nutritional supplements, essential oils, and homoeopathic and herbal preparations are collectively termed and regulated as Complementary Medicines (CMs) by the Australian Therapeutic Goods Administration (TGA). CMs are predominantly self-selected through a pharmacy, providing pharmacy personnel an opportunity to engage with the public about their CM use. CMs are currently non-scheduled products in Australia. This review aimed to summarize the literature reporting the potential effect on pharmacies if scheduling of CMs was adopted, using codeine as an example. A scoping review methodology was employed. Seven databases were searched to identify four key concepts, including: CMs, scheduling and rescheduling, codeine, and pharmacists. Seven studies were included for analysis. The majority of the literature has explored qualitative studies on the perception and opinion of pharmacists in relation to the up-scheduling of codeine. The case of codeine illustrates the possible impact of up-scheduling. If CMs were to be up-scheduled, the accessibility of CMs would be limited to the pharmacy providing a role for pharmacy personnel, including both pharmacists and pharmacy technicians, to counsel on CM use. However, careful collaboration and consideration on how such a regulatory change would impact other key-stakeholders, including CM practitioners, requires both a strategic and collaborative approach.

show abstract

Section: Introductionmentioning

confidence: 99%

Impact of Up-Scheduling Medicines on Pharmacy Personnel, Using Codeine as an Example, with Possible Adaption to Complementary Medicines: A Scoping Review

et al. 2020

Self Cite

View full text Add to dashboard Cite

show abstract

“…Our findings suggest that barriers exist within a range of pharmacy sectors including government, professional associations, education, pharmacy business, pharmacist and research. This information can be used to inform strategies that support pharmacists in extending their role to better address their patients' needs related to HMs use [26,32,33].…”

Section: Discussionmentioning

confidence: 99%

“…Although they are subject to prescribed obligations and responsibilities in the regulatory system and assessment process [32], they were often found ill-equipped to provide professional services [70][71][72]. The implications of this argument has been discussed in detail in previous studies [33][34][35][36] What is relevant to the focus of this study was whether these pharmacists are positioned and supported to address the patients' needs in a coordinated manner. Ideally, a holistic approach that engages both types of pharmacists skillsets in patient care is encouraged [73,74].…”

Section: Discussionmentioning

confidence: 99%

“…With pharmacists playing an increasingly important role in patient care, it is important for the legal and professional obligations of licensed pharmacists stipulated by law to fully correspond to the needs of the general public and the consideration should include the use of HMs, conventional medicines and their concurrent use [33,79]. Appropriate training and education should also be in place.…”

Section: Discussionmentioning

confidence: 99%

“…The interview guide was developed by conducting a careful review of the literature related to the integration of traditional and complementary medicines into pharmacy practice in the US and Australia [28,30,32,33], and pharmacy practice in China [34][35][36] (see Appendix). The interview questions focused on key areas including: (1) integrative medicine; (2) community pharmacists' responsibilities with regards to HMs; (3) factors that prevented community pharmacists from taking up such role; and (4) what it would take to improve their practice.…”

Section: Interview Guidementioning

confidence: 99%

See 2 more Smart Citations

Integrating traditional Chinese medicines into professional community pharmacy practice in China – Key stakeholder perspectives

Yao

Harnett

et al. 2020

European Journal of Integrative Medicine

Self Cite

View full text Add to dashboard Cite

Suspected adverse reactions to medications and food supplements containing Serenoa repens: A worldwide analysis of pharmacovigilance and phytovigilance spontaneous reports

Crescioli

Maggini

Raschi

et al. 2023

Phytotherapy Research

View full text Add to dashboard Cite

The safety of Serenoa repens (SR)‐containing products was evaluated conducting a retrospective worldwide analysis of pharmaco‐ and phytovigilance report forms of suspected adverse reactions (SARs) collected up to 31 January 2022. Multivariate logistic regression was performed to estimate the odds ratios (ORs) of serious SAR. A total of 1810 report forms were analysed; 92% of subjects were males, with a median age of 69 years; 44% of cases were defined as serious. Subjects exposed to dietary supplements had a higher risk of developing serious SARs (OR: 1.60 [95% CI: 1.20–2.15]), as subjects exposed to 2–5 (OR: 1. 83 [95% CI: 1.30–2.58]) or more than 5 (OR: 3.45 [95% CI: 2.36–5.06]) suspect/interacting products. The probability of experiencing serious SAR was higher for subjects exposed to concomitant products (OR: 1.55 [95% CI: 1.15–2.08]), to more than four active compounds (OR: 4.38 [95% CI: 3.21–5.99]) and to SR for more than 14 days (OR: 1.89 [95% CI: 1.10–3, 22]), and lower for subjects exposed to higher doses of SR (OR: of 0.34 [95% CI: 0.20–0.58]). This evidence improves awareness on safety of SR containing products, suggesting the need of a further update of periodic reviews by national and international regulatory agencies.

show abstract

Advancing the pharmacist’s role in promoting the appropriate and safe use of dietary supplements

Cited by 36 publications

References 24 publications

Impact of Up-Scheduling Medicines on Pharmacy Personnel, Using Codeine as an Example, with Possible Adaption to Complementary Medicines: A Scoping Review

Impact of Up-Scheduling Medicines on Pharmacy Personnel, Using Codeine as an Example, with Possible Adaption to Complementary Medicines: A Scoping Review

Integrating traditional Chinese medicines into professional community pharmacy practice in China – Key stakeholder perspectives

Suspected adverse reactions to medications and food supplements containing Serenoa repens: A worldwide analysis of pharmacovigilance and phytovigilance spontaneous reports

Contact Info

Product

Resources

About